Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,976 public trials 742 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease

NCT01599871

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain

Hospital Universitario Nuestra Señora de la Candelaria Santa Cruz de Tenerife, Canary Islands, Spain

Clínica Universitaria de Navarra Pamplona, Navarre, Spain

Hospital del Mar Barcelona, Spain

View Trial Details

Completed

Pilot Study of How Children With Asthma Exacerbations Metabolize Prednisone

NCT01260623

Conditions: Asthma, Asthma Exacerbation, Bronchial Diseases, +7 more
Locations: Pediatric Emergency Department, Children's Hospital, London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Physical Activity Versus Pulmonary Rehabilitation in COPD

NCT02161393

Conditions: Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), +8 more
Locations: Belfast Health and Social Care Trust Belfast, Co Antrim, United Kingdom

Western Health and Social Care Trust Enniskillen, United Kingdom

View Trial Details

Completed

Management of Patients With Respiratory Symptoms in Sweden

NCT02728674

Conditions: Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), +15 more
Locations: Department of Respiratory Medicine and Allergology Lund, Skåne County, Sweden

View Trial Details

Completed

A Comprehensive Care Programme for Patients With Chronic Obstructive Pulmonary Disease

NCT01108835

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: The Chinese University of Hong Kong Hong Kong

View Trial Details

Completed

A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)

NCT01978145

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Mar del Plata, Buenos Aires, Argentina

GSK Investigational Site Quilmes, Buenos Aires, Argentina

GSK Investigational Site San Juan Bautista, Buenos Aires, Argentina

GSK Investigational Site Bahía Blanca, Argentina

View all 52 locations

View Trial Details

Completed

Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

NCT00515502

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Hanover, Lower Saxony, Germany

GSK Investigational Site Berlin, Germany

GSK Investigational Site Hamburg, Germany

View Trial Details

Completed

Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects

NCT00625196

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00642148

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Gauting, Bavaria, Germany

View all 31 locations

View Trial Details

Completed

Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations

NCT01218399

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Lung Diseases, Obstructive

Lung Diseases, Obstructive trial results

Related conditions